Fact-sheet: Cerebral microangiopathy - cerebral small vessel disease
- Chronic white matter ischemia
- Cerebral small vessel disease
Updated on 04/12/2026 at 12:18 PM
View all RADEOS cases associated with this fact-sheet
Definition
Cerebral microangiopathy - cerebral small vessel disease is a generic term referring to brain lesions attributed to disease of the small arteries, arterioles, capillaries, venules, or small veins.
It is characterized by structural changes: tortuous vessel walls, reduced caliber and flow, enlarged Virchow-Robin spaces, and white matter demyelination.
Most common cause of vascular dementia (Binswanger's disease) and a major cause of ischemic and hemorrhagic strokes.
Clinical features
- Asymptomatic: Often an incidental finding on imaging.
- Cognitive impairment: Major cause of cognitive deficit and vascular dementia (100% prevalence in some dementia studies).
- Binswanger's disease: Term used to describe a progressive clinical syndrome of cognitive impairment associated with compatible imaging features (diffuse white matter involvement).
- Risks: Stroke and overall mortality.
Laboratory findings
Cardiovascular risk factors accelerate the lesions: arterial hypertension, diabetes, hypercholesterolemia, and smoking.
Ultrasound
Doppler ultrasound: used for associated macrovascular assessment
CT
Less sensitive than MRI
- Non-enhancing white matter hypodensities (leukoaraiosis), predominating around the ventricular trigones and in the subcortical region.
- Ischemic lacunae: focal hypodensities more pronounced than the areas of diffuse demyelination.
MRI
Reference examination. STRIVE-2 recommendations advocate the following sequences: T1, T2, T2-FLAIR, Diffusion (DWI), GRE or SWI, and TOF MR angiography.
- White matter hyperintensities on T2 and T2-FLAIR, iso- or hypointense on T1 (leukoaraiosis).
- Lacunes: Fluid-filled cavities measuring 3 to 15 mm. On T2-FLAIR, they are hypointense (fluid signal), sometimes with a hyperintense rim, distinguishing them from demyelination (which remains hyperintense on T2-FLAIR).
- Enlarged perivascular spaces: Visible on T2-FLAIR as hypointense lacunar-like images, particularly in the insular and lenticular regions.
- Microbleeds: Identified on susceptibility-weighted sequences (GRE/SWI), predominating in the basal ganglia: Suggests a hypertensive etiology.
- Cerebral atrophy (cortical and subcortical).
The combination of leukoaraiosis and microbleeds is a poor prognostic factor for the occurrence of intracerebral hematomas in hypertensive patients.
Classification
Fazekas score (or Fazekas and Schmidt score): assesses periventricular lesions and deep white matter lesions
- Periventricular hyperintensities, grade: 0= Absent
- 1= Linear or capping hyperintensity
- 2= Periventricular halo
- 3= Irregular periventricular hyperintensities extending into the deep white matter
- Deep white matter hyperintensities, grade: 0= Absent
- 1= Punctate hyperintensities
- 2= Beginning confluence of hyperintensities
- 3= Large confluent hyperintensities

Wahlund grades of white matter and basal ganglia signal abnormalities related to age and vascular risk factors.
- White matter lesions Grade 0: no signal abnormality
- Grade 1: focal abnormalities (hyperintensity on FLAIR and T2)
- Grade 2: beginning confluence
- Grade 3: diffuse involvement
- Basal ganglia lesions Grade 0: no signal abnormality
- Grade 1: a single focal lesion > 5 mm
- Grade 2: more than one focal lesion
- Grade 3: confluent lesions
Differential diagnosis
- CADASIL - Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leucoencephalopathy
- Cerebral amyloid angiopathy: Cortico-subcortical microbleeds, cortical superficial siderosis, and convexity subarachnoid hemorrhage suggest cerebral amyloid angiopathy.
- Ependymitis granularis: Juxtaventricular changes (< 3 mm from the ventricle) related to CSF leakage rather than microangiopathy.
- Other: CNS vasculitis, post-radiation angiopathy, genetic disorders (Fabry disease, MELAS).
- Non-vascular causes: Hyperintensities may also reflect an inflammatory condition such as multiple sclerosis or toxic leukoencephalopathy.